These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 20083688)
1. Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. Wieland CN; Comfere NI; Gibson LE; Weaver AL; Krause PK; Murray JA Arch Dermatol; 2010 Jan; 146(1):21-5. PubMed ID: 20083688 [TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting. Desai N; Allen J; Ali I; Venning V; Wojnarowska F Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220 [TBL] [Abstract][Full Text] [Related]
3. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. Iwata Y; Komura K; Kodera M; Usuda T; Yokoyama Y; Hara T; Muroi E; Ogawa F; Takenaka M; Sato S Arch Dermatol; 2008 Jan; 144(1):41-8. PubMed ID: 18209167 [TBL] [Abstract][Full Text] [Related]
4. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472 [TBL] [Abstract][Full Text] [Related]
5. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China. Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study. Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid. Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881 [TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764 [TBL] [Abstract][Full Text] [Related]
9. Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review. Wang M; Lehman JS; Camilleri MJ; Drage LA; Wieland CN J Am Acad Dermatol; 2019 Aug; 81(2):472-479. PubMed ID: 30928465 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Feng S; Wu Q; Jin P; Lin L; Zhou W; Sang H; Shao C Int J Dermatol; 2008 Mar; 47(3):225-8. PubMed ID: 18289320 [TBL] [Abstract][Full Text] [Related]
11. Absence of anti-BP180 antibodies in mothers of infants with bullous pemphigoid. Chiavérini C; Hamel-Teillac D; Gilbert D; Prost Y Br J Dermatol; 2006 May; 154(5):839-43. PubMed ID: 16634883 [TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis. Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009 [TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari. Atzori L; Deidda S; Aste N G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid. Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641 [TBL] [Abstract][Full Text] [Related]
16. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150 [TBL] [Abstract][Full Text] [Related]
17. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens. Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421 [No Abstract] [Full Text] [Related]
18. Development of an ELISA for the detection of autoantibodies to BP230. Kromminga A; Sitaru C; Hagel C; Herzog S; Zillikens D Clin Immunol; 2004 Apr; 111(1):146-52. PubMed ID: 15093564 [TBL] [Abstract][Full Text] [Related]
19. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients. Bernard P; Bedane C; Bonnetblanc JM Br J Dermatol; 1997 May; 136(5):694-8. PubMed ID: 9205501 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Charneux J; Lorin J; Vitry F; Antonicelli F; Reguiai Z; Barbe C; Tabary T; Grange F; Bernard P Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]